Stanley J. Schmidt
GlaxoSmithKline (United States)(US)
Publications by Year
Research Areas
Synthesis and Biological Evaluation, Steroid Chemistry and Biochemistry, Chemical Synthesis and Analysis, Carbohydrate Chemistry and Synthesis, Natural product bioactivities and synthesis
Most-Cited Works
- → Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of Rapamycin(2010)368 cited
- → New IDH1 mutant inhibitors for treatment of acute myeloid leukemia(2015)176 cited
- → P1 Aspartate-Based Peptide .alpha.-((2,6-Dichlorobenzoyl)oxy)methyl Ketones as Potent Time-Dependent Inhibitors of Interleukin-1.beta.-Converting Enzyme(1994)147 cited
- → Discovery of GSK1070916, a Potent and Selective Inhibitor of Aurora B/C Kinase(2010)109 cited
- → Palladium catalysed alkoxycarbonylation of phenols to benzoate esters(1987)98 cited
- → Discovery of a Potent Class of PI3Kα Inhibitors with Unique Binding Mode via Encoded Library Technology (ELT)(2015)74 cited
- → Discovery of the First Potent and Selective Inhibitor of Centromere-Associated Protein E: GSK923295(2010)64 cited
- → Studies on the active site of succinyl-CoA:tetrahydrodipicolinate N-succinyltransferase. Characterization using analogs of tetrahydrodipicolinate.(1986)54 cited
- → Nonpeptidic urotensin‐II receptor antagonists I: in vitro pharmacological characterization of SB‐706375(2005)53 cited
- → Pyridazinodiazepines as a High-Affinity, P2−P3Peptidomimetic Class of Interleukin-1β-Converting Enzyme Inhibitor(1997)52 cited